التفاصيل البيبلوغرافية
| العنوان: |
46P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from the adjuvant phase of the randomised, open-label, multicentre phase III (neo)adjuvant FeDeriCa study |
| المؤلفون: |
Im, S-A.1, Tan, A.R.2, Mattar, A.3, Colomer, R.4, Stroyakovskii, D.5, Nowecki, Z.6, De Laurentiis, M.7, Pierga, J-Y.8, Jung, K.H.9, Schem, C.10, Aguila, C.11, Badovinac Crnjevic, T.11, Heeson, S.12, Shivhare, M.13, Alexandrou, A.14, Restuccia, E.11, Jackisch, C.15 |
| المصدر: |
Annals of Oncology. 2021 Supplement 2, Vol. 32, pS40-S41. 2p. |
| مصطلحات موضوعية: |
*BREAST cancer treatment, *TRASTUZUMAB, *COMBINATION drug therapy |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder